Samuel Levy
Technik-/Wissenschafts-/F&E-Leiter bei ClearNote Health, Inc.
Profil
Samuel Levy is currently the Chief Scientific Officer at ClearNote Health, Inc. He previously held the position of Chief Scientific Officer at Genomic Health, Inc. Dr. Levy completed his undergraduate degree at the University of Leeds and obtained a doctorate degree from the University of Bristol.
Aktive Positionen von Samuel Levy
| Unternehmen | Position | Beginn |
|---|---|---|
ClearNote Health, Inc.
 ClearNote Health, Inc. Pharmaceuticals: MajorHealth Technology ClearNote Health, Inc. is a company that develops liquid biopsy tests to detect cancers with high mortality rates early when they respond best to treatment. ClearNote Health is based in San Mateo, CA. The company uses its proprietary epigenomics platform to analyze individuals' changing biology that is yet to produce symptoms. The company was founded by Stephen D. Quake, and David Mullarkey has been the CEO of the company since 2022. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ehemalige bekannte Positionen von Samuel Levy
| Unternehmen | Position | Ende |
|---|---|---|
| GENOMIC HEALTH, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Samuel Levy
| University of Leeds | Undergraduate Degree |
| University of Bristol | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Genomic Health, Inc.
 Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA. | Health Technology |
ClearNote Health, Inc.
ClearNote Health, Inc. Pharmaceuticals: MajorHealth Technology ClearNote Health, Inc. is a company that develops liquid biopsy tests to detect cancers with high mortality rates early when they respond best to treatment. ClearNote Health is based in San Mateo, CA. The company uses its proprietary epigenomics platform to analyze individuals' changing biology that is yet to produce symptoms. The company was founded by Stephen D. Quake, and David Mullarkey has been the CEO of the company since 2022. | Health Technology |
